Who Just RaisedBiotech & pharma that raised money in Washington
In the last 30 days, 1 biotech & pharma business in Washington reported raising $25K on SEC Form D. The largest was Q-Immune, Inc. ($25K).
- New raises
- 6
- Capital reported
- $6.9M
- Median raise
- $750K
Aug 3, 2026 to Oct 16, 2026
sold to investors so far
among raises with sales
| Company | Location | Sector | Raised | Target | Filed |
|---|---|---|---|---|---|
| Q-Immune, Inc. | Seattle, WA | Health Care | $25K | $1M | |
| Hexamer Therapeutics, Inc | Pullman, WA | Health Care | $500K | $2.5M | |
| Aptevo Therapeutics Inc. | Seattle, WA | Health Care | $3.5M | $3.5M | |
| MalarVx, Inc. | Seattle, WA | Health Care | $125K | $2.5M | |
| Strella Biotechnology, Inc. | Seattle, WA | Health Care | $1.8M | $3.3M | |
| Automera US Inc. | Seattle, WA | Health Care | $1M | $7M |
Biotech & pharma nationwide · All raises in Washington · Filter these →